Roivant Sciences’ mission is to systematically reduce the time, cost, and risk of delivering new medicines to market by accelerating the development of promising drug candidates to improve the lives of patients and their families. The company is privately held, has in-licensed 25+ assets, and is very well-capitalized. The Investments team focuses on acquiring, developing, and commercializing clinical drug candidates that can benefit from Roivant’s clinical development expertise and/or offer innovative alternative development pathways that can be significantly value-accretive.
Position Summary: This position is a unique role among biotechnology companies as it more closely resembles a buy-side investor role, rather than a conventional business development position in a biopharmaceutical company. In this role, you will be responsible for building the scientific/clinical rationale and investment case for novel drug development ideas and drug acquisition targets. Because it involves the sourcing, assessment, and in-licensing of new assets and new company creation, this position is essential to achieving Roivant’s growth targets and company mission.
Responsibilities
- Understand the broad biotech/pharmaceutical market landscape and clinical development process for marketing approval
- Review, aggregate, analyze and monitor pharmaceutical development databases and market research reports
- Help develop and grow a robust pipeline of targets by searching publicly available databases and online resources for novel drug development ideas
- Create and maintain an internal database of potential acquisition candidates
- Conduct in-depth scientific, clinical and market research and financial modeling to support recommendations
- Help inform the investment thesis through rigorous modeling of potential commercial launch trajectories and revenue projections
- Construct persuasive investment theses in the form of PowerPoint presentations and supporting Excel models
- Communicate theses directly to senior management advocating for specific drug development projects
- Partner with senior members of the Investment group to assist with all elements of transactions on new investments through closing, including due diligence, valuation, deal structuring, and negotiations
Skills & Qualifications
- Familiarity with the major scientific and medical aspects of drug development
- Strong scientific and analytical skills and attention to detail
- Experience writing research reports and delivering presentations that integrate multiple data sources
- Proficiency with MS Office suite, including functions and pivot tables (Word, Excel, and PowerPoint)
- Experience using multiple pharmaceutical competitive intelligence databases
- Excellent written and verbal communication skills
- Ability to work cross-functionally within the organization (marketing, R&D, finance, etc.)
Experience & Education Requirements
- Two to three years of buy-side healthcare investing experience, primarily focused on therapeutics (or the equivalent 5-7 years of skill-building in a related discipline (e.g., VC, sell side research)
- Bachelor’s degree required (preferably in science); advanced degree (e.g., PhD, MD, MBA, MSc) preferred
Working Conditions
- Dynamic, interactive, fast-paced office environment
- Limited domestic or international travel may be required
Compensation
- Competitive compensation and benefits package, including initial equity grant
- Significant bonus compensation upon contribution of a drug development idea(s) that add value to the organization
- Equity grants are offered annually for top performers
If interested, please apply here.
